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Abstract
Certain microbes invade brain microvascular endothelial cells (BMECs) to breach the blood-brain barrier (BBB) and establish
central nervous system (CNS) infection. Here we use the leading meningitis pathogen group B Streptococcus (GBS) together
with insect and mammalian infection models to probe a potential role of glycosaminoglycan (GAG) interactions in the
pathogenesis of CNS entry. Site-directed mutagenesis of a GAG-binding domain of the surface GBS alpha C protein impeded
GBS penetration of the Drosophila BBB in vivo and diminished GBS adherence to and invasion of human BMECs in vitro.
Conversely, genetic impairment of GAG expression in flies or mice reduced GBS dissemination into the brain. These
complementary approaches identify a role for bacterial-GAG interactions in the pathogenesis of CNS infection. Our results
also highlight how the simpler yet genetically conserved Drosophila GAG pathways can provide a model organism to screen
candidate molecules that can interrupt pathogen-GAG interactions for future therapeutic applications.
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Introduction
Bacterial meningitis is one of the top ten causes of infection-
related mortality worldwide [1]. Meningitis is particularly devas-
tating in the newborn infant, and 20–50% of survivors can suffer
permanent neurological sequelae including deafness, seizures,
hydrocephalus, cerebral palsy and/or cognitive deficits [2–5]. The
most common agent of neonatal bacterial meningitis in the United
States, Europe and Asia is group B Streptococcus (GBS). In recent
years, GBS has also emerged as a cause of serious infections
including meningitis in nonpregnant adult populations, with an
invasive disease incidence approaching that reported for the
neonate [6–8]. In gaining access to the central nervous system
(CNS), GBS reveals an ability to cross the blood-brain barrier
(BBB), a specialized layer of brain microvascular endothelial cells
(BMECs) that regulates macromolecular traffic to maintain
biochemical homeostasis in brain tissues. BBB penetration by a
bacterial pathogen reflects a complex interplay between host
endothelium and microbial products [9]. The fundamental
mechanisms by which GBS establishes CNS infection remain
incompletely understood [10].
The plasma membrane of mammalian endothelial cells is
prominently decorated with linear, negatively charged sugar
chains known as glycosaminoglycans (GAGs). The sulfated GAGs,
chondroitin/dermatan sulfate and heparan sulfate, occur as
proteoglycans that consist of one or more GAG chains covalently
linked to a core protein. Cells elaborate several membrane
heparan sulfate proteoglycans (HSPGs) including syndecans and
the glycosylphosphatidylinositol-linked glypicans. The heparan
sulfate chains assemble by copolymerization of alternating residues
of N-acetylglucosamine and glucuronic acid, which then can
undergo variable sulfation and uronic acid epimerization. This
process occurs in a non-template driven manner, resulting in
sections of the chains with variably modified sugars of variable
length interspersed with domains of unmodified residues. The
modified regions make up binding sites for growth factors,
membrane receptors, and extracellular matrix constituents,
imparting to the chains important biological activities, such as
roles in cell adhesion, receptor signaling, and leukocyte trafficking
across endothelium [11]. The ability of an individual cell to
interact with and respond to ligands appears to depend on the
array of expressed proteoglycans and the pattern of modifications
of the heparan sulfate chains [12–14]. Proteoglycan synthesis in
mammals is a complex process involving a diverse array of gene
products including core proteins, enzymes that initiate and
elongate the polysaccharide chain, and enzymes that modify the
polymer by sulfation and other processes [15,16]. Drosophila
melanogaster contains a repertoire of GAG structures similar to that
of mammals [17] through a relatively small number of genes
highly homologous to those found in mammals [18,19].
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with cell surface GAGs [14]. Examples include the initial
attachment phase of herpes simplex virus mediated through
heparan sulfate [20,21], Mycobacterium tuberculosis lung epithelial
invasion through expression of a heparin-binding protein [22], and
heparan sulfate-dependent attachment and entry of intestinal
epithelial cells by Listeria monocytogenes [23]. We hypothesized that
direct interactions with GAGs expressed on BMECs could
influence the propensity of bloodborne bacteria to breach the
BBB and produce CNS infection. In the specific case of GBS, a
candidate ligand for this process exists in the surface-anchored
Alpha C protein (ACP), which has the capacity to bind GAGs and
promote bacterial entry into cervical epithelial cells in vitro [24–26].
Drosophila can serve as a useful model organism for analysis of
mechanisms of bacterial pathogenesis and resistance [27–30]. We
have recently shown that GBS infection can be established in
Drosophila, and that overall mortality and bacterial loads are
reduced in fly strains with diminished GAG expression [31]. In the
present study, we use bacterial, Drosophila, and mouse mutants to
achieve the aim of examining the role of bacterial-GAG
interactions as mediators of BBB translocation and CNS infection.
The study highlights an emerging recognition that specialized
surface glial cells regulate the flow of substances into and out of the
fly brain and present a functional equivalent of the BBB in
Drosophila [32–35]. Our findings indicate that the specific heparan
sulfate-binding properties of ACP promote BBB interactions and
contribute to the establishment of GBS meningitis.
Results
GAG binding by ACP facilitates GBS dissemination into fly
heads
We previously demonstrated that pricking the Drosophila thorax
with a needle that had been dipped into a concentrated slurry of
GBS leads to fly death [31]. To assess the nature of bacterial
dissemination from the prick site, we performed histologic
examination of GBS-infected Drosophila. As shown (Figure S1 A
and B), wild-type (WT) GBS A909 spreads systemically after
localized injection in the thorax. H&E stain reveals bacterial cocci
in multiple sites, including muscle, fat, and the lining of the brain.
These data indicate that tissue architecture is largely preserved
despite widespread GBS dissemination during infection. The
mutant GBS strain A909/R185A harbors a single amino acid
change in ACP that significantly reduces GAG binding without
affecting overall ACP structure, bacterial growth rate, or surface
polysaccharide capsule expression [26,31]. Following pinprick
inoculation of an identical dose of the A909/R185A mutant into
the fly thorax, bacteria disseminate less broadly from the local site
of infection, and fewer cocci are visualized at the brain lining
(Figure S1 C and D) To specifically address whether ACP-GAG
binding promotes GBS dissemination into fly heads, we compared
the bacterial burden (colony forming units, cfu) in the heads and
bodies of WT flies after infection with WT GBS A909 and A909/
R185A mutant. Flies infected with mutant bacteria had a
significantly lower ratio of head cfu to total (head+body) cfu than
those infected with the WT strain (Figure 1A; Supplemental Table
S1), indicating that disruption of ACP-GAG binding decreases
GBS penetration into the fly head.
Impaired Drosophila GAG expression reduces GBS
dissemination into fly heads
The Drosophila genome contains genes encoding the HSPG core
proteins dally, dally-like protein [dlp] and syndecan [sdc]; three genes
encoding heparan sulfate polymerases, tout-velu [ttv] (homolog of
mammalian Ext1), sister of ttv [sotv] (homolog of Ext2)a n dbrother of ttv
[botv] (homolog of Extl3); and one gene encoding an N-deacetylase-
N-sulfotransferase (sulfateless [sfl], a homolog of Ndst1). After chain
initiation by Botv, polymerization occurs through a copolymerase
complex consisting of Ttv and Sotv [36]. The GAG chains then
undergo a series of modifications such as N-deacetylation and N-
sulfation of N-acetylglucosamine residues by Sfl. Mutations in these
genes lead to altered content or sulfation of heparan sulfate on all
Drosophila heparan sulfate proteoglycans [37,38].
To corroborate the role of GAG binding in GBS dissemination
into the fly head, we used the pinprick method to establish
infection in three different HSPG mutant fly strains deficient in
membrane HSPG core proteins (dally+dlp+sdc), heparan sulfate
polymerases (ttv+sotv), or NDST (sfl), respectively. After infection
with WT GBS A909, all three HSPG mutant fly strains exhibited
lower head/total body cfu ratios than did the WT control flies
(Figure 1B; Supplemental Table S1). The extent of reduction in
head/total body cfu probably underestimates the importance of
HSPGs in this model since each of the host mutations had to be
tested as heterozygotes due to the requirement for HSPGs in fly
embryogenesis.
We next sought to specifically link the observed GAG-
dependent phenotype to glial cells that form tight junctions and
restrict paracellular diffusion between the fly circulatory system
and brain, thereby representing the Drosphila BBB equivalent [33].
The glial cell-specific driver repo-Gal4 was used to suppress
polymerase expression in fly BBB cells through in vivo shRNA
knockdown of ttv, sotv, and botv. After infection with WT GBS
A909, flies with glial cell-specific knockdown of either botv alone, or
both ttv and sotv displayed higher survival rates than the
corresponding repo and Gal4-UAS controls (Figure 1 C and D).
GAG binding by GBS ACP promotes human BMECs
adherence and invasion. Immortalized human BMECs have
provided a widely used and well-defined in vitro model for under-
standing microbial interactions with the human BBB [9,39].
Previous studies have shown that fetal or adult primary BMECs
expressed high levels of heparan and chondroitin sulfates [40],
supporting earlier conclusions that proteoglycans are richly
expressed on the surface of primary human endothelial cells
derived from all age groups, including the fetus [41–43]. We found
that WT GBS A909 efficiently adhered to and invaded hBMECs;
however the A909/R185A mutant with decreased GAG-binding
Author Summary
Streptococcus agalactiae (Group B Streptococcus, GBS) is a
leading cause of meningitis in human newborn infants.
The bacterial and host factors that allow this pathogen to
cross the blood-brain barrier (BBB) and cause central
nervous system (CNS) infection are not well understood.
Here we demonstrate that GBS expresses a specific protein
on its surface that can bind to sugar molecules known as
glycosaminoglycans (GAGs) on the surface of brain
capillary cells, initiating infection of the BBB. Fruit flies or
mice genetically engineered to have reduced GAGs
showed decreased dissemination of GBS into the brain
tissues following experimental infection. Our results
identify a role for bacterial-GAG interactions in the
pathogenesis of newborn meningitis and highlight how
the simpler yet genetically conserved fruit fly GAG
biosynthetic pathways make the fruit fly a good model
organism to screen candidate molecules that can interrupt
pathogen-GAG interactions for future therapeutic applica-
tions.
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cells(Figure2 Aand B).Similarresultswereobtainedwheninfection
and invasion were measured in A549 lung adenocarcinoma cells
(Figure S2 A and B). To further establish a role for GAG binding in
GBS interaction with hBMECs, we used RNA interference to
silence the expression of EXT2. The efficiency of silencing was over
80% by qRT-PCR analysis of mRNA from hBMECs infected with
EXT2 shRNA lentiviruses compared to hBMECs infected with a
control lentivirus (Figure 2C). Although no apparent difference in
WT GBS A909 adherence to control vs. EXT2 knockdown
hBMECs was discerned (Figure 2D), GBS invasion of hBMECs
followingEXT2 knockdownwassignificantlydecreased(Figure 2E).
Reduced GAG expression diminishes GBS BBB
penetration in a murine meningitis model
Mice heterozygous for Ext2 provide a functional in vivo model in
which the chain length of GAGs expressed by the host is
significantly reduced [44]. To confirm the utility of this model for
analysis of GBS-BBB interactions, we isolated and cultured primary
Figure 1. ACP-GAG binding promotes GBS invasion into fly heads; glial GAG polymerase knock-down decreases lethal infection.
(A) The ratio of head/whole fly cfu in WT yw flies 24 h after infection with GBS mutant R185A (filled bar, n=13 groups of 10 flies) was significantly
lower than after infection with WT GBS strain A909 (open bar, n=14 groups of 10 flies). (B) The ratios of head to whole fly cfu in HSPG mutant flies
(filled bars) were lower than those in the WT control flies (open bar, n=22 groups of 10 flies). The HSPG mutant flies studied here carry mutations in
the genes encoding core proteins (dally+dlp+sdc, n=15 groups of 10 flies), GAG polymerases (ttv+sotv, n=12 groups of 10 flies) or the GAG NDST (sfl,
n=10 groups of 10 flies. Infected flies were heterozygotes from crosses of these mutants with yw flies, as homozygous mutants in these genes are
nonviable. Each bar represents the mean and SEM. The student’s t-test was used for statistical analysis in each comparison. ** p,0.01; *** p,0.001.
Repo-Gal4 is a pan-glial Gal4 driver [66]. Flies expressing shRNA targeting both ttv and sotv (C) or botv alone (D) driven by repo-Gal4 show resistance
to lethal A909 infection. Plots show a pool of data from at least 60 flies per sample. The genotypes of the flies used here are repo-Gal4/+ (repo), UAS-
sotvRNAi/+;UAS-ttvRNAi/+ (sotvRNAi+ttvRNAi), UAS-sotvRNAi/+;UAS-ttvRNAi/repo-Gal4 (repo.sotvRNAi+ttvRNAi), UAS-botvRNAi/+ (botvRNAi) and
UAS-botvRNAi/repo-Gal4 (repo.botvRNAi). The Gal4 and UAS lines were crossed with yw flies as controls. The survival curves of yw, Gal4 controls,
UAS controls, and shRNA expressing groups are indicated as open circles, open squares, open diamonds, and filled circles respectively. A log rank test
was used for statistical analysis in comparing shRNA-expressing groups and control groups.
doi:10.1371/journal.ppat.1002082.g001
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+/2 mice (Ext2 hets) and WT
littermate controls and infected them ex vivo with WT GBS A909.
We documented an approximate 40% reduction in heparan sulfate
content of endothelium isolated from these Ext2 het mice vs. WT
controls (Figure S3). GBS adherence and invasion were significantly
reduced in mBMECs from Ext2 hets compared to those isolated
from WT mice (Figure 3 A and B). Several factors may explain why
adherence was altered in Ext2 het mBMECs but not in Ext2-
silenced hBMECs, including differences in residual GAG quantity
or structure or overall surface charge, other effects of using
transformed vs. primary cells, or species-specific effects. Of note,
Ext2-silencing was associated with reduced hBMEC growth rate,
while Ext2 het mBMECs grew similarly to WT mBMECs.
Moreover, impaired GBS adherence and invasion was also
observed in Ndst1-deficient mBMECs that exhibit overall
reduction in sulfation of the chains (Figure 3 C and D) [36,37].
Comparable results were obtained in Ndst1-deficient mouse lung
endothelial cells (Figure S2 C and D). To explore a potential
contribution of mammalian GAG expression to GBS BBB
penetration in vivo, Ext2 hets and WT littermate controls were
infected intravenously with WT GBS A909 and sacrificed 24 h
later. Significantly fewer bacterial cfu (9-fold decrease) were
Figure 2. Contribution of GAG-binding activity of GBS to adherence and invasion of hBMECs. For adherence (A), bacteria were
enumerated after 30 min of incubation, whereas invasion (B) was quantified after 2 h of incubation with human brain microvascular endothelial cells
(hBMECs) and 2 h of incubation with antibiotics to kill extracellular bacteria. (C) Knockdown of EXT2 expression by RNA interference. hBMECs were
infected with lentiviruses carrying control shRNA or EXT2 targeting shRNA and the knockdown efficiency was determined by quantitative RT-PCR.
GAPDH was used as an internal control. Attenuation of A909 invasion (E) but not adherence (D) after knocking down EXT2 expression in hBMECs.
Adherence and invasion assays were performed in triplicate and repeated three times with similar results, and representative experiments are shown.
Statistical analysis was performed by Student’s t test and error bars SEM. * p,0.05; ** p,0.01; *** p,0.001.
doi:10.1371/journal.ppat.1002082.g002
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PLoS Pathogens | www.plospathogens.org 4 June 2011 | Volume 7 | Issue 6 | e1002082Figure 3. GAG contributes to blood-brain barrier penetration in mice in vivo. Attenuated GBS adhesion (A, C) and invasion (B, D) to primary
mBMECs from Ext2 heterozygous mice (ext2 hets) and Ndst1-deficient mice. For adherence, bacteria were enumerated after 30 min of incubation,
whereas invasion was quantified after 2 h of incubation with mBMECs and 2 h of incubation with antibiotics to kill extracellular bacteria. Comparison
of bacterial counts (expressed in cfu) recovered from the brain (E), blood (F), and spleen (G) of WT mice and Ext2 hets 24 h after intravenous
challenge with 10
8 cfu of A909. (H) Brain bacterial counts were corrected for blood contamination (brain/blood ratio) using the blood concentration
and a conservative estimate of the mouse cerebral blood volume (2.5 ml per 100 g tissue). Results pool the data from two independent experiment
with final numbers of n=12 for WT and n=11 for Ext2 het. Each circle denotes 1 mouse. Statistics analysis was performed by Student’s t test (A–D) or
Mann-Whitney test (E–H). *p,0.05.
doi:10.1371/journal.ppat.1002082.g003
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brains of WT controls (Figure 3E) and some animals showed
dramatic 10
3–10
4 fold reduction in brain cfu. In contrast, lesser
decreases in bacterial cfu were observed in the blood (Figure 3F)
and spleen (Figure 3G) of Ext2 hets. Consequently, the mean ratio
of brain:blood cfu in Ext2 hets (10.6) was significantly lower than
that observed in WT controls (116.0) (Figure 3H). In a small pilot
experiment, we noted a trend of reduced CFU in the lungs of Ext2
hets compared to WT mice (Figure S4), suggested that the finding
may extend to other endothelium, but such conclusions require
future corroboration. Bone-marrow derived macrophages from
Ext2 hets and WT controls did not differ in assays of phagocytosis,
total bacterial killing, intracellular bacterial killing, or release of
tumor necrosis factor-alpha when challenged with GBS ex vivo
(Figure S5), indicating that reduced GAG expression does not
globally compromise phagocyte innate immune function. In sum,
the reduction of GAG expression resulting from EXT2 heterozy-
gosity diminishes GBS interactions with BMECs in vitro and
decreases GBS CNS entry in vivo.
Discussion
Our combined analyses in the Drosophila and mammalian
systems indicate that GBS interaction with GAGs promotes BBB
attachment and bacterial entry into the CNS. The GAG binding
property of the surface-anchored ACP is one contributor to this
invasive phenotype. Meningitis is a dangerous complication of
neonatal GBS infection and understanding the predilection of the
pathogen to breach the BBB is a critical goal of molecular
pathogenesis investigations. To date, a number GBS factors have
been shown to promote its interaction with human BMECs in vitro,
including fibrinogen adhesin FbsA [38], laminin-binding protein
Lmb [45], major pilus backbone subunit PilB [46], lipoteichoic
acid anchoring enzyme IagA [47], and the serine-rich repeat 1
glycoprotein Srr1 [48]. In the case of IagA, Srr1, and the hBMEC-
disrupting GBS ß-hemolysin/cytolysin, a contribution to menin-
gitis in the murine model has further been demonstrated [47–49].
However, the present study is the first to genetically manipulate
the host to identify the corresponding host receptor molecules
(GAGs) that the GBS virulence factor (ACP) exploits to adhere to
and invade the BBB endothelium.
Mammalian heparin sulfate chain polymerization reactions are
carried out by the exostosin proteins EXT1 and EXT2 [50,51] and
subsequent modification of the chains by the bifunctional NDSTs.
We found decreased GBS invasion in both hBMECs with shRNA-
reduced EXT2 levels (Figure 2E) and primary Ext2 heterozygous
mBMECs (Figure 3B). In additional studies, we found reduced GBS
adherence to and invasion of Ndst1-deficient mBMECs (Figure 3 C
and D) and lung endothelial cells (Figure S2 C and D). Adherence
and invasion of the A909/R185A mutant to A549 human lung
epithelial cells were also markedly attenuated compared to the WT
GBS A909 (Figure S2 A and B). Thus the GAG-ACP interaction
may contribute to GBS penetration of a broader spectrum of host
cell barriers, and GAG expression patterns may determine the
nature and efficiency of bacterial dissemination during infection.
Moreover, our findings suggest that the chain lengths and negative
charges on the GAG chains are both important to provide the
binding forces between ACP and GAGs. These findings are
consistent with prior data demonstrating that specific positively
charged residues of ACP are required for full ACP-GAG binding
affinity [26]. Whether ACP binds to a specific sequence of sulfated
sugars within heparan sulfate remains to be determined. The
availability of mutants altered in 2-O-sulfation of uronic acids, and
3-O- and 6-O-sulfation of glucosamine residues will allow further
studies on the structural specificity of the interaction in flies [52,53]
and in mice [54,55].
Our parallel findings in flies and in mammals both in vitro and in
vivo support the relevance of a Drosophila infection model for the
study of human CNS infections. Others have reported that the
Drosophila humoral/CNS barrier conserves the xenobiotic exclu-
sion properties of vertebrate vascular endothelium. Specifically,
the exclusion process is mediated in part by a fly ATP binding
cassette (ABC) transporter, Mdr65, that functions similarly to
mammalian xenobiotic blood-brain barrier transporters. Thus,
CNS chemoprotection involves both conserved molecular struc-
tures and functionally analogous anatomic spaces that together
promote CNS selective drug partition [34]. Our data extend these
findings by demonstrating that CNS penetration of microorgan-
isms may also occur via conserved molecular structures (GAGs),
and that these structures can be studied effectively in a Drosophila
infection model.
Many microorganisms display GAG-binding ability, including
the two leading bacterial pathogens associated with meningitis in
older children and adults: Streptococcus pneumoniae utilizes heparin,
heparan sulfate and chondroitin/dermatan sulfate in colonization
of respiratory mucosal epithelial cells [56], and Neisseria meningitidis
surface protein OpC binds HS proteoglycans to initiate epithelial
cell invasion [57]. Sulfated GAGs also promote adherence of the
veterinary meningeal pathogen Haemophilus somnus to bovine
BMEC in vitro [58]. However, each of these GAG-binding
interactions has uncertain functions in the pathogenesis of CNS
infection that could be difficult to pinpoint because of functional
redundancy of bacterial adhesins/invasins and the challenges of
manipulating GAG structure/expression in complex mammalian
host systems. The importance of positively charged residues is a
common theme among GAG-binding proteins. For example, the
C-terminal regions of mycobacterial heparin-binding hemaggluti-
nin [59] and histone-like Hlp protein [60] contain Arg/Lys-rich
repeats important for heparin binding. In some instances,
common heparin-binding motifs, such as BBXB, BBBXXB (B
representing a basic amino acid residue), and a 20 A ˚ spacing of
basic residues have been reported [61,62]. Positively charged
residues of ACP that were confirmed to contribute to GAG
binding by site-directed mutagenesis were R172, R185 and K196;
two of these (R185 and K196) are completely conserved in other
members of the alpha-like protein (Alp) including Rib, Alp1, Alp2,
Alp3 and Alp4 of GBS and R28 of group A Streptococcus [26].
The Drosophila infection model offers the advantages of a simpler
genome and well-developed molecular approaches that will
facilitate interrogation of host-pathogen GAG-binding interac-
tions, and allow testing of candidate inhibitors of these interactions
with an eye toward future therapeutic applications. The design of
inhibitors targeting particular pathogen virulence mechanisms
represents an attractive strategy in the era of increasing resistance
to conventional antibiotics. In attempting to block bacterial-GAG
interactions, a major limitation to competitive inhibition by
heparin itself is its potency as an anticoagulant and the risk of
hemorrhagic complications. However, synthetic low-molecular
weight heparins or analogs devoid of anticoagulant activity could
be contemplated in this context as potential adjunctive agents for
infectious disease therapeutics.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. The protocol was
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PLoS Pathogens | www.plospathogens.org 6 June 2011 | Volume 7 | Issue 6 | e1002082approved by the Institutional Animal Care and Use Committee of
the University of California, San Diego (Animal Welfare Assurance
Number: A3033-01). All efforts were made to minimize suffering of
animals employed in this study.
Bacteria and cell lines
The ACP-expressing human serotype Ia GBS neonatal isolate,
A909, was used in this study. A909/R185A is an A909 point
mutant strain that has an ACP variant with diminished GAG
binding affinity [26]. GBS were grown in Todd-Hewitt broth
(THB, Difco) at 37uC. SV40 large T antigen immortalized human
brain endothelial cell line (hBMEC) was obtained from Kwang Sik
Kim (Johns Hopkins University, Baltimore, MD). hBMECs were
maintained in RPMI 1640 medium (Invitrogen) supplemented
with 10% FBS, 10% NuSerum (BD), and 1% MEM nonessential
amino acids, and were incubated at 37uCi n5 %C O 2.
Mice and murine primary brain microvascular endothelial
cell isolation
Murine brain microvascular endothelial cells (mBMEC) were
isolated from cerebral cortex as described [63], except that cells
were selected with 5 mg/ml puromycin for 4 days in low-glucose
DMEM medium supplemented with 20% FBS (Atlanta Biologi-
cals), 50 mg/ml endothelial growth supplement (BTI), 50 mg/ml
heparin, nonessential amino acids, penicillin and streptomycin.
Cell purity was higher than 98% as assessed by blood endothelial
markers including CD31, CD34, CD105 and CD166. Primary
cells were cultured for 5 days and passaged once for experiments.
Lung microvascular endothelial cells were isolated as described
previously [64]. Ext2
+/2 mice were described previously [44].
Endothelial cells lacking Ndst1 were derived from Ndst1
f/fTie2Cre
+
mice [64,65].
Fly infections
In infection experiments, bacteria were grown to an optical
density at 650 nm of 0.3, and then concentrated 10-fold to
approximately 2610
9 cfu/ml; the exact bacterial concentration
was confirmed in each experiment. Adult male flies (2 to 5 days
old) were anesthetized with CO2 and then pricked in the dorsal
thorax underneath the wing with a fine needle previously dipped
in THB broth or a concentrated solution of GBS in THB. After
infection, flies were incubated at 29uC in vials with food, and fly
survival was monitored over the following 4 days. Cumulative
survival curves were derived, and the median survival time for
each group was determined using Kaplan-Meier survival analysis.
A log rank test was performed to compare survival curves.
To determine the bacterial load in fly heads and bodies at 24 h
after infection, flies were placed on ice, and fly heads were
separated from fly bodies by a sterile surgical blade. The heads and
bodies of 10 flies per group were homogenized in 500 ml and
1000 ml of phosphate-buffered saline (PBS) with 0.025% Triton
X-100 respectively. The homogenates were diluted in series
(usually 10
21 to 10
23), and the dilutions were plated on THB
plates and incubated overnight at 37uC for cfu counting.
Adherence and invasion assay
BMECs were split into 24-well plates and allowed to grow to
confluence for 48 h prior to assays, to ensure similar cell numbers
for each experiment. Confluent monolayers were incubated with
log-phase grown bacteria at an MOI of 1 or 10, and centrifuged at
1600 rpm for 5 min to initiate contact. After 2 h incubation, the
monolayers were washed, and 1 mL of media containing 100 mg
of gentamicin and 5 mg of penicillin G was added for an additional
2 h. After washing, monolayers were disrupted by 0.025% Triton
X-100, and the number of invasive bacteria was quantified by
serial dilution plating. To assess the level of surface-adherent (total
cell-associated) bacteria, bacteria were quantified after 30 min of
incubation without addition of antibiotics. All cellular adherence
and invasion assays were performed in triplicate and repeated at
least 2–3 times.
RNA interference
Human ext2 lentiviral shRNA construct (TRCN0000039849)
was purchased from Open Biosystems. The resulting viruses were
produced by cotransfection of 293T cells with the shRNA plasmid
and packaging vectors (Open Biosystems) according to the vendor’s
instruction. The knockdown efficiency was determined by qRT-
PCR analysis of ext2 expression. Primers used for qRT-PCR were
EXT2 forward, 59-AAGCACCAGGTCTTCGATTACC-39 and
reverse, 59-GAAGTACGCTTCCCAGAACCA-39. and GAPDH
forward 59-GAAGGTGAAGGTCGGAGTCAACG-39 and reverse
59-TCCTGGAGGATGGTGATGGAAT-39.
Mouse infection model
Ext2 heterozygous and littermate controls (10–12 weeks) were
injected via the tail vein with 10
8 cfu A909. Twenty-four h after
injection, samples of blood, brain/meninges, and spleen were
collected aseptically from mice after euthanasia. Bacterial counts
in blood and tissue homogenates were determined by plating serial
dilutions. Bacterial counts in brain and spleen samples were
corrected for differences in organ weight. Brain bacterial counts
were corrected for blood contamination using the blood
concentration and a conservative estimate of the mouse cerebral
blood volume [47]. In a pilot experiment, additional Ext2
heterozygous and littermate controls were injected intravenously
with 1610
8 cfu of WT GBS and lungs harvested at 24 h for cfu
determination. The significance of differences between treatment
groups was determined using the unpaired Student t test.
Supporting Information
Figure S1 Wild-type (OreR) Drosophila were pricked in the
thorax with a needle dipped in a concentrated slurry (approx
2610
9 cfu/ml) of GBS wild-type strain A909 or A909/R185A,
then incubated at 29uC in vials with food for 24 h, fixed in
formalin, sectioned, and stained with H&E. No organisms were
seen in control samples that were pricked with a needle dipped in
sterile THB alone. (A) A909 infiltrating fat and muscle tissue, (B)
A909 in clumps lining the brain (arrow). Tissue architecture is
largely preserved despite widespread GBS dissemination. R185A
spreads minimally if at all to (C) muscle and (D) CNS.
(TIF)
Figure S2 ACP-sulfated GAG interaction promotes GBS
adherence and invasion of lung epithelial cells. GAG-binding
diminished GBS mutant (R185A, filled bars) showed reduced
adherence (A) and invasion (B) of A549 WT human lung epithelial
cells compared to WT GBS strain A909 (open bars). Compared to
wild-type cells, adherence (C) and invasion (D) of murine Ndst1-
deficient lung endothelial cells (mLECs) by A909 (filled bars) were
reduced. R185A results (open bars) are also shown. For adherence,
bacteria were enumerated after 30 min of incubation, whereas
invasion was quantified after 2 h of incubation with cells and 2 h
of incubation with antibiotics to kill extracellular bacteria.
Adherence and invasion assays were performed in triplicate and
repeated three times with similar results, and representative
experiments are shown. Statistical analysis was performed by
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** p,0.01; *** p,0.001.
(TIF)
Figure S3 Reduction of heparan sulfate in lung endothelial cells
isolated from Ext2+/2 mice. Radiolabeled (
35S) glycosaminogly-
cans were purified by column chromatography, proteinase- and
chondroitinase-treated and heparan sulfate content of eluted
material calculated by
35S content.
(TIF)
Figure S4 Pilot experiment comparing lung cfu from WT vs.
Ext2 het mice 24 h following intravenous infection. Statistics
analysis was performed by Mann-Whitney test.
(TIF)
Figure S5 WT and Ext2 het macrophages exhibited similar
responses to GBS stimulation. Murine bone marrow-derived
macrophages (MBDMs) were used for in vitro assays to examine
phagocytosis (A), bacterial killing (B and C; WT, filled bars; Ext2
het, open bars) and TNF-a secretion (D; A909, filled bars; R185A,
open bars) after GBS infection. For phagocytosis, A909 was added
to MBDMs at MOI=5 for 30 min, followed by 2 h of incubation
with antibiotics to kill extracellular bacteria. Intracellular survival
of A909 was performed at multiplicity of infection=5 bacteria/
cell. MBDMs were incubated with A909 for 60 min, followed by
2 h of incubation with antibiotics to kill extracellular bacteria.
Intracellular colony forming units (CFU) were enumerated by the
lysis of cells at the indicated time points. Total bacterial killing was
performed at MOI=0.1. For TNF-a assay, MBDMs were
stimulated with A909 at MOI=5 for 30 min, followed by 24 h
of incubation with antibiotics. Supernatant was collected for
ELISA assay to determine the TNF-a concentration.
(TIF)
Table S1 Head and body CFU counts in Drosophila melanogater
infected with group B Streptococcus. This table provides all the
primary data used in the calculations of Figure 1 A of the main
text.
(DOC)
Text S1 Supplemental methods describing the measurement of
heparan sulfate in primary mouse lung microvascular endothelial
cells.
(DOC)
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